PharmGKB summary: very important pharmacogene information for PTGS2.
about
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resourceColorectal cancer drug target prediction using ontology-based inference and network analysis.Celecoxib pathways: pharmacokinetics and pharmacodynamics.Pharmacogenetic considerations in the treatment of gout.The Effects of Simazine, a Chlorotriazine Herbicide, on the Expression of Genes in Developing Male Xenopus laevis.
P2860
PharmGKB summary: very important pharmacogene information for PTGS2.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
PharmGKB summary: very important pharmacogene information for PTGS2.
@ast
PharmGKB summary: very important pharmacogene information for PTGS2.
@en
type
label
PharmGKB summary: very important pharmacogene information for PTGS2.
@ast
PharmGKB summary: very important pharmacogene information for PTGS2.
@en
prefLabel
PharmGKB summary: very important pharmacogene information for PTGS2.
@ast
PharmGKB summary: very important pharmacogene information for PTGS2.
@en
P2093
P2860
P1476
PharmGKB summary: very important pharmacogene information for PTGS2.
@en
P2093
Caroline F Thorn
Teri E Klein
Tilo Grosser
P2860
P304
P356
10.1097/FPC.0B013E3283415515
P50
P577
2011-09-01T00:00:00Z